We compared the outcome of patients treated for an intertrochanteric fracture of the femoral neck with a locked, long intramedullary nail with those treated with a dynamic hip screw (DHS) in a prospective randomised study.
The debate continues about how best to treat extra-capsular fractures of the hip. Operative fixation remains the mainstay of treatment. In theory, there is an advantage to using an intramedullary device as it reduces the bending moment across the implant/fracture construct.
1,2 The most recent Cochrane review states that, given the higher overall complication rate associated with intramedullary devices, the sliding hip screw is, or appears to be, a better method of treating intertrochanteric hip fractures.
1
A variety of intramedullary devices have been used. Their complications are welldocumented and include fracture below the stem, failure of fixation, and the complications of distal locking. 1, [3] [4] [5] [6] The use of a trochantericentry nail has been shown to reduce the risk of fracture of the neck and upper part of the femur. 7, 8 However, most of the literature to date has compared short intramedullary devices with the sliding hip screw.
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The use of a long trochanteric-entry nail in the low-energy subtrochanteric fracture has been shown to have an acceptable level of post-operative complications and give a favourable functional outcome. 13 However, to our knowledge, there are no prospective randomised trials that compare the functional outcome of patients with an intertrochanteric hip fracture treated by fixation with a long trochanteric-entry intramedullary nail or a dynamic hip screw (DHS; Biomet, Swindon, United Kingdom).
The Holland nail (Biomet) is a trochantericentry point femoral nail. It has a proximal diameter of 13 mm and the long nail is avail-able with a 9 mm or 12 mm distal diameter. It can be locked proximally into the femoral neck with two 7 mm partiallythreaded cannulated screws to achieve rotational stability and distally with two 4 mm static locking partiallythreaded bolts.
The aim of treating an intertrochanteric hip fracture is to produce a stable construct that allows early mobilisation and weight-bearing but with minimal complications. The hypothesis of this study was that patients mobilise faster after a Holland nail than after a DHS. Their operation time, intra-operative blood loss, imaging time, rate of wound infection, time to fracture union and mobility after one year were also compared.
Patients and Methods
Following approval from the local ethics committee, each patient who presented to the Accident and Emergency department with an extracapsular fracture of the neck of the femur was evaluated for inclusion in this study. We included any patient with a low-energy extracapsular intertrochanteric fracture. The fractures were graded using the AO/Association for the Study of Internal Fixation (ASIF) classification (A1-3) (Fig. 1) .
14 Only those with a subtrochanteric extension of the fracture were excluded.
After giving informed consent, patients were allocated a sequential study number and were randomised by computer to be treated either with a DHS or a Holland nail. The pre-and post-operative care was the same for both groups. There were no exclusions after randomisation.
A total of 190 patients were enrolled, 92 in the Holland nail group and 98 in the DHS group. There were 84 women in the Holland nail group and 78 in the DHS group (Table I) .
Pre-operative care and variables. Each patient was made as fit as possible before their operation. Their fitness for surgery was independently assessed by the consultant anaesthetist who was administering the anaesthetic. The individual patient American Society of Anaesthesiologists (ASA) score, 15 Mini Mental test score 16 and pre-admission mobility were recorded. Mobility was assessed using the Parker and Palmer mobility score (Table II) .
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Intra-operative care. Each patient was given a single-dose antibiotic teicoplanin (Aventis Pharma, Kings Hill, United Kingdom) and gentamicin at induction. The method of anaesthesia was either regional, regional and general, or general. The anaesthetic was given by a specialist registrar or consultant anaesthetist. The total time of anaesthesia was recorded from entry to the anaesthetic room to entry to the operating theatre.
Patients were then transferred to a traction table where closed reduction of the fracture was carried out. A standard operative technique either recommended by the manufacturer or by previous studies was used.
14, 18 The length of the Holland nail was measured from the tip of the greater trochanter to the superior pole of the patella before skin incision and confirmed intra-operatively. Each procedure was carried out by a specialist registrar under supervision or by a consultant who was familiar with both procedures. The length of the operation, total radiation time and blood loss were recorded. The length of the operation from skin incision to skin closure was recorded. Dynamic hip screw isolation drapes (Ioban Steri-drape, Bracknell, United Kingdom) were used as an aid to accurate assessment of the intra-operative blood loss. The total blood loss was calculated by adding the volume of blood on the swabs to that in the drapes. This was independently assessed and recorded by the anaesthetist. Post-operative care. Appropriate prophylaxis against infection (teicoplanin and gentamicin for 24 hours after surgery) and thromboembolism was routinely given to all patients. Low-risk patients were given 150 mg aspirin once daily for six weeks, whereas high-risk patients received low-molecular-weight 40 mg subcutaneous heparin once daily while in hospital, then 150 mg aspirin once daily after discharge for six weeks. Pain relief was standardised.
Patients received a blood transfusion if their haemoglobin fell below 8 g/dl or if they became symptomatic with a haemoglobin level between 8 g/dl and 10 g/dl.
The patient's wounds were inspected on the first and seventh days by an independent surgeon. Any oozing wounds were swabbed and those that were infected were classified using established guidelines 19 and treatedwith the appropriate antibiotics for five to seven days.
Patients were mobilised fully weight-bearing on the first post-operative day. Their rehabilitation was standardised regardless of the type of fixation used. The time taken to mobilise with a frame and duration of hospital stay were independently assessed and recorded.
Follow-up was at six weeks, six months and one year post-operatively. Plain anteroposterior and lateral radiographs were taken at each visit and reviewed for fracture union or implant failure. The patient's mobility at one year was assessed using the Parker and Palmer mobility score.
Statistical analysis. Statistical analysis was performed using SPSS for Windows (SPSS Inc., Chicago, Illinois). Using time taken to mobilise with a frame as a primary outcome measure, a sample size of 80 in each group was needed to show a 20% difference (α = 0.05; β = 0.80; SD 0.5 of mean). Additional patients were recruited to allow for possible attrition. The unpaired independent ttest was used to compare study outcome measures with parametric means. The chi-squared test and Fisher's exact test were used to compare non-parametric means. The level of significance was set at p < 0.05.
Results
The 30-day mortality was similar for both the Holland nail and DHS groups (seven patients (7.6%) vs six patients (6.1%), respectively and no patient was lost to follow-up (Fig. 2) . At one year, 76 patients were reviewed in the Holland nail group and 80 in the DHS group. The demographic and pre-operative variables of the two groups were comparable (Table I) . We found no difference in the type of anaesthesia given to each group. However, the mean anaesthetic and operation times were longer in the Holland nail group (40.4 vs 29.7 minutes, p < 0.001, and 54 vs 40.3 minutes, p < 0.001, respectively). There was significantly increased mean blood loss in DHS group (160 ml vs 78 ml, respectively, p < 0.001) and more patients needed a post-operative blood transfusion in the DHS group (23 vs seven, p = 0.003). The mean radiation time was significantly longer in the Holland nail group (1.56 min vs 0.9 min, p < 0.001). All results are shown in Table III .
There were more wound infections requiring antibiotics in the DHS group (ten patients vs five), although the difference was not statistically significant (p = 0.286). No wound was re-opened, and all had healed after six weeks. There was one patient with a deep-vein thrombosis in the DHS group who was treated with warfarin for six months. No patient had a pulmonary embolus, but 13 (six Holland nail, seven DHS) developed a post-operative chest infection which required treatment with antibiotics. One patient in the DHS group had a transient ischaemic attack. There were two implant failures (2%) in the DHS group, one of which was revised to a Holland nail 12 days after the index DHS procedure and this patient was excluded from the one-year analysis. The proximal screws migrated laterally in four patients (4.3%) with a Holland nail: all were treated conservatively. There was no significant difference in implant failures between the groups. No proximal or distal femoral fracture was noted in the Holland nail group.
The mean time to mobilisation with a frame was significantly shorter in the Holland nail group (3.6 vs 4.3 days, p = 0.012). After one year, every fracture had united. Patients who had a Holland nail were significantly more mobile than those with a DHS (mobility score: 5.9 vs 3.8, p < 0.001) and were more likely to regain their pre-operative mobility score (49 patients vs 30 patients, p < 0.001).
Discussion
The best treatment of extracapsular hip fractures remains a matter for debate. In 2005, the Cochrane review compared a variety of implants used to treat these fractures.
1 They found that a Gamma nail performed no better than a DHS, and recommended the DHS as the implant of choice on the basis of the higher level of complications with the Gamma nail. Moreover, they found no advantage in using a proximal femoral nail for these fractures.
The Holland nail is similar to the proximal femoral nail in having two proximal locking screws. It differs in its proximal diameter (13 mm vs 15 mm) and the size of the locking screws. In this study, each patient in the Holland nail group received a long distally-locked nail (Fig. 3) . These have previously been used to treat subtrochanteric and high-energy proximal femoral fractures to good effect. 9, 13, 20 To the best of our knowledge, no previous study has assessed the use of the Holland nail in the treatment of intertrochanteric fractures.
There are two previous controlled studies comparing the mobility of patients treated with a proximal femoral nail or a DHS. Pajarinen et al 21 randomised 108 patients with lowenergy extracapsular pertrochanteric fractures to have either a proximal femoral nail or a DHS. After four months, they found that patients in the proximal femoral nail group were more likely to have regained their preoperative level of mobility than those in the DHS group. However, their ability to walk was the same. They suggested that the impaction of the fracture in the DHS group led to femoral neck shortening and a mechanical disadvantage compared with the proximal femoral nail. Conversely, Saudan et al 10 reported a reduction in mobility after one year in patients treated with a proximal femoral nail compared with those treated with a DHS. Our study shows that one year after the index operation, patients who received a Holland nail were 50% more mobile than those with a DHS. Moreover, 64% of patients in the Holland nail group regained their pre-fracture mobility, compared with 37% in the DHS group. This is in line with previous studies of the proximal femoral nail and Gamma nail, which reported a restoration of mobility in 40% to 70% of patients. 8, 11, 21 However, our study uses a more comprehensive system for measuring mobility. Fogagnolo et al 12 have shown that only 32% recover their Parker and Palmer mobility score four months after a proximal femoral nail. The Holland nail is similar to the proximal femoral nail, and although the one-year radiographs were not assessed for shortening of the femoral neck or shaft, it would seem reasonable that the improvement in mobility can be attributed to improved restoration of hip anatomy and biomechanics. Our study also shows that the time taken to mobilise with a frame is shorter with the Holland nail than with the DHS. The reason for this may be any combination of postoperative factors: pain, muscle dysfunction and medical comorbidities. The Holland nail is implanted through a small incision above the greater trochanter. This entry point causes less damage to the superior gluteal nerve and gluteus medius muscle than other entry points in the piriform fossa. 22 The DHS, however, requires a larger incision and probably damages more muscle. We also found a doubling of the intra-operative blood loss when using the DHS and three times as many patients needed a blood transfusion, which slowed their mobilisation.
The anaesthetic, operating and radiation times were longer in the Holland nail group. This may be a function of the learning curve in its use, but we were unable to compare the grade of doctor with the duration of the procedure because of the small sample size. There were also more superficial and deep infections in the DHS group (DHS, ten vs Holland nail, five), but this did not reach statistical significance (p = 0.286). There were no post-operative femoral fractures in either group, and only one DHS was revised for implant failure. There are several limitations to this study. Post-operative pain was not measured in every patient and is, therefore, not presented. This was because of the varied mental capacity of patients within each group (Mini-Mental test scores ranging from 0 to 10 for both groups). Although every radiograph was examined for component failure, measurements of the femoral neck and shaft were not recorded. This may have provided further evidence to support the improved post-operative mobility seen in the Holland nail group. The sample size was estimated using mobility as the primary outcome measure. Larger sample sizes would be needed to provide useful subgroup analysis. There were, in addition, more A3 fractures in the Holland nail group. There was no bias to place patients with A3 fractures in this group, and the small numbers of each fracture type may account for this difference.
This study shows that the Holland nail can be used safely to treat all intertrochanteric fractures. It has a low rate of complications and allows patients to mobilise more quickly and to a higher level than the DHS. It is now the implant of choice in our unit.
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